IN2014DN03005A - - Google Patents
Info
- Publication number
- IN2014DN03005A IN2014DN03005A IN3005DEN2014A IN2014DN03005A IN 2014DN03005 A IN2014DN03005 A IN 2014DN03005A IN 3005DEN2014 A IN3005DEN2014 A IN 3005DEN2014A IN 2014DN03005 A IN2014DN03005 A IN 2014DN03005A
- Authority
- IN
- India
- Prior art keywords
- protein
- acid sequences
- adenoviral
- adenovirus
- pertaining
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
- C12N15/86—Viral vectors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/155—Paramyxoviridae, e.g. parainfluenza virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/10011—Adenoviridae
- C12N2710/10041—Use of virus, viral particle or viral elements as a vector
- C12N2710/10043—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/10011—Adenoviridae
- C12N2710/10311—Mastadenovirus, e.g. human or simian adenoviruses
- C12N2710/10322—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/10011—Adenoviridae
- C12N2710/10311—Mastadenovirus, e.g. human or simian adenoviruses
- C12N2710/10333—Use of viral protein as therapeutic agent other than vaccine, e.g. apoptosis inducing or anti-inflammatory
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/10011—Adenoviridae
- C12N2710/10311—Mastadenovirus, e.g. human or simian adenoviruses
- C12N2710/10341—Use of virus, viral particle or viral elements as a vector
- C12N2710/10343—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Genetics & Genomics (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Virology (AREA)
- General Health & Medical Sciences (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- General Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Biochemistry (AREA)
- Medicinal Chemistry (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Microbiology (AREA)
- Physics & Mathematics (AREA)
- Plant Pathology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Immunology (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Mycology (AREA)
- Pulmonology (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Communicable Diseases (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Oncology (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201161543638P | 2011-10-05 | 2011-10-05 | |
| PCT/US2012/058956 WO2013052799A2 (en) | 2011-10-05 | 2012-10-05 | Adenoviral vectors and methods of use |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IN2014DN03005A true IN2014DN03005A (enExample) | 2015-05-08 |
Family
ID=47045178
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IN3005DEN2014 IN2014DN03005A (enExample) | 2011-10-05 | 2012-10-05 |
Country Status (8)
| Country | Link |
|---|---|
| US (4) | US9233153B2 (enExample) |
| EP (1) | EP2764012B1 (enExample) |
| JP (2) | JP6757119B2 (enExample) |
| CN (1) | CN103974969B (enExample) |
| BR (1) | BR112014008167B1 (enExample) |
| CA (1) | CA2850629C (enExample) |
| IN (1) | IN2014DN03005A (enExample) |
| WO (1) | WO2013052799A2 (enExample) |
Families Citing this family (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2764011B1 (en) * | 2011-10-05 | 2021-04-07 | GenVec, Inc. | Adenoviral vector-based respiratory syncytial virus (rsv) vaccine |
| IN2014DN03005A (enExample) | 2011-10-05 | 2015-05-08 | Genvec Inc | |
| US9629906B2 (en) | 2011-10-05 | 2017-04-25 | Genvec, Inc. | Affenadenovirus (gorilla) or adenoviral vectors and methods of use |
| JP6757121B2 (ja) | 2011-10-05 | 2020-09-16 | ジェンヴェック エルエルシー | シミアン（ゴリラ）アデノウイルス又はアデノウイルスベクター、及び使用方法 |
| EP2855511B1 (en) | 2012-05-29 | 2019-07-24 | GenVec, Inc. | Herpes simplex virus vaccine |
| JP6983665B2 (ja) * | 2015-06-12 | 2021-12-17 | グラクソスミスクライン バイオロジカルズ ソシエテ アノニム | アデノウイルスポリヌクレオチド及びポリペプチド |
| CN109863169A (zh) | 2016-08-23 | 2019-06-07 | 葛兰素史密丝克莱恩生物有限公司 | 具有连接至不变链(cd74)的短片段的抗原的融合肽 |
| EP3518966A1 (en) | 2016-09-29 | 2019-08-07 | GlaxoSmithKline Biologicals S.A. | Compositions and methods of treatment of persistent hpv infection |
| US11155832B2 (en) | 2016-09-30 | 2021-10-26 | Genvec, Inc. | Adenovectors for delivery of therapeutic genetic material into T cells |
| GB201616904D0 (en) | 2016-10-05 | 2016-11-16 | Glaxosmithkline Biologicals Sa | Vaccine |
| EP3522920A2 (en) | 2016-10-10 | 2019-08-14 | Transgene SA | Immunotherapeutic product and mdsc modulator combination therapy |
| CA3045976A1 (en) | 2016-12-09 | 2018-06-14 | Glaxosmithkline Biologicals Sa | Chimpanzee adenovirus constructs with lyssavirus antigens |
| GB201701239D0 (en) | 2017-01-25 | 2017-03-08 | Glaxosmithkline Biologicals Sa | Novel formulation |
| CN111108192B (zh) * | 2017-07-05 | 2023-12-15 | Nouscom股份公司 | 非人类人猿腺病毒核酸序列和氨基酸序列、含有其的载体及其用途 |
| WO2019016756A1 (en) | 2017-07-21 | 2019-01-24 | Glaxosmithkline Biologicals Sa | ANTIGEN CONSTRUCTS OF CHIKUNGUNYA VIRUSES |
| JP7581048B2 (ja) | 2018-03-06 | 2024-11-12 | プレシゲン，インコーポレイテッド | ヒトパピローマウイルスワクチンおよびその使用 |
| IL277128B2 (en) | 2018-03-06 | 2025-11-01 | Precigen Inc | Hepatitis b vaccines and uses of the same |
| EP3587581A1 (en) | 2018-06-26 | 2020-01-01 | GlaxoSmithKline Biologicals S.A. | Formulations for simian adenoviral vectors having enhanced storage stability |
| WO2021072129A2 (en) | 2019-10-08 | 2021-04-15 | Trustees Of Boston College | Proteins containing multiple, different unnatural amino acids and methods of making and using such proteins |
| US20230085724A1 (en) | 2020-03-05 | 2023-03-23 | Neotx Therapeutics Ltd. | Methods and compositions for treating cancer with immune cells |
Family Cites Families (36)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2705686B1 (fr) | 1993-05-28 | 1995-08-18 | Transgene Sa | Nouveaux adénovirus défectifs et lignées de complémentation correspondantes. |
| KR100356615B1 (ko) | 1993-07-13 | 2003-04-03 | 아방티 파르마 소시에테 아노님 | 결함아데노바이러스벡터및유전자치료에서그의사용 |
| WO1995016772A1 (en) | 1993-12-14 | 1995-06-22 | Cornell Research Foundation, Inc. | Adenovirus gene expression system |
| ATE336587T1 (de) | 1994-06-10 | 2006-09-15 | Genvec Inc | Adenoviren-vektor systeme und zelllinien |
| US5851806A (en) | 1994-06-10 | 1998-12-22 | Genvec, Inc. | Complementary adenoviral systems and cell lines |
| US5998205A (en) | 1994-11-28 | 1999-12-07 | Genetic Therapy, Inc. | Vectors for tissue-specific replication |
| IL116816A (en) | 1995-01-20 | 2003-05-29 | Rhone Poulenc Rorer Sa | Cell for the production of a defective recombinant adenovirus or an adeno-associated virus and the various uses thereof |
| ATE445705T1 (de) | 1995-06-15 | 2009-10-15 | Crucell Holland Bv | Verpackungssysteme für humane rekombinante adenoviren zur gentherapie |
| US5837511A (en) | 1995-10-02 | 1998-11-17 | Cornell Research Foundation, Inc. | Non-group C adenoviral vectors |
| EP0885012A4 (en) | 1996-01-29 | 2001-09-05 | Univ Georgetown | MALARIA Vaccine, which also contains an MSA1 peptide |
| US6113913A (en) | 1998-06-26 | 2000-09-05 | Genvec, Inc. | Recombinant adenovirus |
| US6225289B1 (en) | 1998-12-10 | 2001-05-01 | Genvec, Inc. | Methods and compositions for preserving adenoviral vectors |
| AU2001234981A1 (en) * | 2000-02-09 | 2001-08-20 | Genvec, Inc. | Adenoviral capsid containing chimeric protein ix |
| US6821519B2 (en) | 2000-06-29 | 2004-11-23 | Corixa Corporation | Compositions and methods for the diagnosis and treatment of herpes simplex virus infection |
| US20040136963A1 (en) | 2001-06-22 | 2004-07-15 | The Trustees Of The University Of Pennsylvania | Simian adenovirus vectors and methods of use |
| US6677156B2 (en) | 2001-07-23 | 2004-01-13 | Genvec, Inc. | Non-adenoviral gene product-based complementing cells for adenoviral vectors |
| AU2002327380A1 (en) | 2001-07-23 | 2003-03-18 | Genvec, Inc. | Cells and methods for propagating adenoviral vectors |
| US6682929B2 (en) | 2001-07-23 | 2004-01-27 | Genvec, Inc. | Adenovector complementing cells |
| WO2003022311A1 (en) | 2001-09-13 | 2003-03-20 | Genvec, Inc. | Adenoviral vector and related system and methods of making and use |
| WO2005075506A1 (en) * | 2004-01-09 | 2005-08-18 | The Scripps Research Institute | Identification of endogenous trimerization domains in the adenovirus fiber protein that allow detargeting and retargeting of viral vectors |
| CN101208425B (zh) * | 2004-12-13 | 2011-01-26 | 坎吉有限公司 | 产生复制缺陷型腺病毒的细胞系 |
| WO2007027860A2 (en) | 2005-08-31 | 2007-03-08 | Genvec, Inc. | Adenoviral vector-based malaria vaccines |
| WO2007073513A2 (en) | 2005-11-10 | 2007-06-28 | Genvec, Inc. | Method for propagating adenoviral vectors encoding inhibitory gene products |
| EP2521786B1 (en) | 2006-07-20 | 2015-06-24 | Vical Incorporated | Compositions for vaccinating against hsv-2 |
| ES2552688T3 (es) | 2008-10-31 | 2015-12-01 | The Trustees Of The University Of Pennsylvania | Adenovirus de simio con proteínas de la cápside hexónica de SAdV-46 y usos del mismo |
| AU2010209938A1 (en) * | 2009-02-02 | 2011-08-25 | Glaxosmithkline Biologicals Sa | Simian adenovirus nucleic acid- and amino acid-sequences, vectors containing same, and uses thereof |
| RU2012107702A (ru) | 2009-07-31 | 2013-09-10 | Пэксвэкс, Инк. | Векторы на основе аденовирусов |
| EA201270607A1 (ru) * | 2009-11-09 | 2012-09-28 | Генвек, Инк. | Аденовирус обезьян и способы его использования |
| WO2011140296A1 (en) | 2010-05-05 | 2011-11-10 | Infinity Pharmaceuticals | Triazoles as inhibitors of fatty acid synthase |
| WO2012021730A2 (en) | 2010-08-11 | 2012-02-16 | Genvec, Inc. | Respiratory syncytial virus (rsv) vaccine |
| IN2014DN03005A (enExample) | 2011-10-05 | 2015-05-08 | Genvec Inc | |
| EP2764011B1 (en) * | 2011-10-05 | 2021-04-07 | GenVec, Inc. | Adenoviral vector-based respiratory syncytial virus (rsv) vaccine |
| JP6757121B2 (ja) * | 2011-10-05 | 2020-09-16 | ジェンヴェック エルエルシー | シミアン（ゴリラ）アデノウイルス又はアデノウイルスベクター、及び使用方法 |
| US9629906B2 (en) * | 2011-10-05 | 2017-04-25 | Genvec, Inc. | Affenadenovirus (gorilla) or adenoviral vectors and methods of use |
| WO2013116591A1 (en) * | 2012-02-02 | 2013-08-08 | Genvec, Inc. | Adenoviral vector-based malaria vaccine |
| EP2855511B1 (en) | 2012-05-29 | 2019-07-24 | GenVec, Inc. | Herpes simplex virus vaccine |
-
2012
- 2012-10-05 IN IN3005DEN2014 patent/IN2014DN03005A/en unknown
- 2012-10-05 CN CN201280059666.3A patent/CN103974969B/zh active Active
- 2012-10-05 EP EP12775110.5A patent/EP2764012B1/en active Active
- 2012-10-05 US US14/349,421 patent/US9233153B2/en active Active
- 2012-10-05 WO PCT/US2012/058956 patent/WO2013052799A2/en not_active Ceased
- 2012-10-05 CA CA2850629A patent/CA2850629C/en active Active
- 2012-10-05 BR BR112014008167-0A patent/BR112014008167B1/pt active IP Right Grant
- 2012-10-05 JP JP2014534767A patent/JP6757119B2/ja active Active
-
2016
- 2016-01-11 US US14/992,152 patent/US9725738B2/en active Active
-
2017
- 2017-07-14 US US15/650,289 patent/US10260074B2/en active Active
-
2018
- 2018-07-20 JP JP2018137235A patent/JP6970059B2/ja active Active
-
2019
- 2019-02-22 US US16/282,924 patent/US11034975B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| US20160122781A1 (en) | 2016-05-05 |
| BR112014008167B1 (pt) | 2022-05-24 |
| EP2764012B1 (en) | 2022-02-23 |
| US20180066281A1 (en) | 2018-03-08 |
| CN103974969B (zh) | 2018-06-29 |
| US11034975B2 (en) | 2021-06-15 |
| US20140248307A1 (en) | 2014-09-04 |
| US9233153B2 (en) | 2016-01-12 |
| EP2764012A2 (en) | 2014-08-13 |
| JP2018198602A (ja) | 2018-12-20 |
| JP6970059B2 (ja) | 2021-11-24 |
| CN103974969A (zh) | 2014-08-06 |
| JP2014530604A (ja) | 2014-11-20 |
| US20190316152A1 (en) | 2019-10-17 |
| CA2850629A1 (en) | 2013-04-11 |
| JP6757119B2 (ja) | 2020-09-16 |
| WO2013052799A2 (en) | 2013-04-11 |
| CA2850629C (en) | 2024-05-21 |
| US10260074B2 (en) | 2019-04-16 |
| BR112014008167A2 (pt) | 2017-04-11 |
| US9725738B2 (en) | 2017-08-08 |
| WO2013052799A3 (en) | 2013-07-04 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IN2014DN03061A (enExample) | ||
| IN2014DN03005A (enExample) | ||
| WO2013052832A3 (en) | Simian (gorilla) adenovirus or adenoviral vectors and methods of use | |
| WO2015168547A3 (en) | In vivo gene engineering with adenoviral vectors | |
| SG10201607968WA (en) | Artificial nucleic acid molecules for improved protein or peptide expression | |
| PH12012500908A1 (en) | Methods of propagating monkey adenoviral vectors | |
| AU2011356210A8 (en) | Novel fucosyltransferases and their applications | |
| EP2582397A4 (en) | COMPOUNDS AND METHOD FOR MODULATING INTERACTION BETWEEN PROTEINS AND TARGET NUCLEIC ACIDS | |
| ZA201309016B (en) | Simian adenovirus and hybrid adenoviral vectors | |
| WO2012027572A3 (en) | Methods for nucleic acid capture and sequencing | |
| IL228328B (en) | Aav vectors without capsid, preparations and methods for vector preparation and gene transfer | |
| WO2013052859A3 (en) | Adenoviral vector-based respiratory syncytial virus (rsv) vaccine | |
| GB0922209D0 (en) | Proteins, nucleic acid molecules and compositions | |
| IT1395511B1 (it) | Apparato per riscaldamento con microonde di prodotti planari | |
| WO2012142434A8 (en) | Aav mediated ctla-4 gene transfer to treat sjogren's syndrome | |
| WO2013119302A3 (en) | Gh61 polypeptide variants and polynucleotides encoding same | |
| EP2592944A4 (en) | BEVERAGES WITH HIGH PROTEIN CONTENT AND WHEY PROTEINS | |
| FR2994849B1 (fr) | Formulation pour la delivrance de sequences nucleotidiques susceptibles de moduler des mecanismes endogenes d'arn interferents | |
| PL3461888T3 (pl) | Ulegające zużyciu krioprezerwowane komórki wykazujące przejściową nadekspresję genu(-ów) kodującego(-ych) białko(-a) transportera leku i/lub enzym(y) metabolizujący(-e) lek | |
| WO2017041063A3 (en) | Compositions and methods for identifying genetic predisposition to obesity and for enhancing adipogenesis | |
| PL2681532T3 (pl) | Wyznaczanie DNA i/lub RNA na podstawie danych ze spektrofotometru UV-VIS | |
| SG10201705118RA (en) | Dna element having the activity of enhancing foreign gene expression | |
| GB201004143D0 (en) | Promoter sequence for DNA and viral vectors | |
| WO2009143277A3 (en) | Compositions comprising hscn9a sirna and methods of use thereof | |
| IL227261A0 (en) | Means for creating adenoviral vectors for cloning large nucleic acids |